XML 83 R71.htm IDEA: XBRL DOCUMENT v3.23.1
Share-based Payments (Tables)
12 Months Ended
Dec. 31, 2022
Text block [abstract]  
Summary of Details of Share-Based Payments
Details of share-based payments granted by the Controlling to executives and employees, including the CEO, by the resolution of the
Board
of
Directors
for the years ended December 31, 2021 and 2022, are as follows:
 
    
2021
(
i
n share)
  
15th grant
Grant date
   June 17, 2021
Grantee
  
CEO
, internal directors, external directors, executives
Vesting conditions
   Service condition: 1 year Non-market performance condition: achievement of performance
Fair value per option
(in Korean won)
  
32,397
Total compensation costs
(in Korean won)
  
5,005 million
Estimated exercise date (exercise date)
  
May 11, 2022
Valuation method
   Fair value method
   
(
i
n share)
  
Employee wage negotiation
Grant date
   September 6, 2021
Grantee
   All employees
Vesting conditions
   Current employees as of September 6, 2021
Fair value per option
(in Korean won)
  
30,950
Total compensation costs
(in Korean won)
  
40,083 million
Estimated exercise date (exercise date)
   December 10, 2021
Valuation method
   Fair value method
   
    
2022
(in share)
  
16th grant
Grant date
   June 9, 2022
Grantee
   CEO, internal directors, external directors, executives
Vesting conditions
  
Service condition: 1 year
Non-market performance condition: achievement of performance
Fair value per option
(in Korean won)
  
36,941
Total compensation costs
(in Korean won)
  
6,222 million
Estimated exercise date (exercise date)
   During 2023
Valuation method
   Fair value method
Summary of Changes in the Number of Stock Options and the Weighted-Average Exercise Price
Changes in the number of stock options and the weighted-average exercise price as at December 31, 2021 and 2022, are as follows:
 
(In share)
  
2021
 
    
Beginning
    
Grant
    
Expired
   
Exercised
 1
   
Ending
    
Number of
shares
exercisable
 
14th grant
     398,856        —          (264,286     (134,570     —          —    
15th grant
     —          284,209        —         —         284,209        —    
Employee wage negotiation
     —          1,432,332        —         (1,432,332     —          —    
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
    
 
 
 
Total
     398,856        1,716,541        (264,286     (1,566,902     284,209        —    
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
    
 
 
 
   
(In share)
  
2022
 
    
Beginning
    
Grant
    
Expired
   
Exercised
 1
   
Ending
    
Number of
shares
exercisable
 
15th grant
     284,209        —          (155,286     (128,923     —          —    
16th grant
     —          258,509        —         —         258,509        —    
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
    
 
 
 
Total
     284,209        258,509        (155,286     (128,923     258,509        —    
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
    
 
 
 
 
  1
The weighted average price of ordinary shares at the time of exercise
, during the year ended December 31,
2022
is
35,450 (2021:
31,122).